Other

Fujian Akeylink Biotechnology Co., Ltd.

Shandong Danhong Pharmaceutical Co., Ltd.

Fujian Cosunter Pharmaceutical Co., Ltd.

Shangdong Danhong Pharmaceutical Co., Ltd.

Yaxun Yang

Haiying He

Jian Li

Shuhui Chen

Peng Li

Zhi Luo

Lele Yang

Xiaolin Li

Jing Wang

Zhigan Jiang

Chen Zhang

Zheng Wang

Peng Shao

Jianchen Zhang

Disclosed are a ring-modified proline short peptide compound and the use thereof, and specifically disclosed is a compound represented by formula (X) or a pharmaceutically acceptable salt thereof.

Ring-modified proline short peptide compound and use thereof

Disclosed are a process route of a compound of a compound of formula (IV), a crystal form and a preparation method therefor. Also disclosed is an application of the crystal form in preparation of drugs for treating diseases associated with SSAO.

Process route of compound of formula (IV), crystal form and preparation method therefor

Disclosed are crystal form A and crystal form B of a compound represented by formula (I), and application thereof in the preparation of medicaments for treating HBV-related diseases.

Crystal form of tri-cycle compound and application thereof

The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof. 

SSAO inhibitor

Disclosed in the present invention are a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt, and applications thereof in the preparation of drugs for treating HBV-related diseases. 

Tri-cycle compound and applications thereof

Growing community of inventors

Shanghai, China

Yaxun Yang